Search Results
Page 35 of 7720. Total results: 77196
- https://harshbarger.house.gov/sites/evo-subsites/harshbarger.house.gov/files/evo-media-document/DH%20PBM%20Act%20Text.pdf...—The term “pharmacy benefit manager” means any person, business, or other entity, such as a third-party administrator, regardless of whether such person, business, or entity identifies itself as a pharmacy benefit manager, that, either directly or indirectly through an intermediary (including an affiliate, subsidiary, or agent) or an arrangement with a third party— (A) acts as a negotiator of prices, rebates, fees, or discounts for prescription drugs on behalf of a health plan or health plan sponsor; (B) contracts with pharmacies to create pharmacy networks and designs and manages such networks; or (C) manages or administers the prescription drug benefits provided by a health plan, including the processing and payment of claims for prescription drugs, arranging alternative access to or funding for prescription drugs, the performance of utilization management services, including drug utilization review, the processing of drug prior authorization requests, the adjudication of appeals or grievances related to the prescription drug benefit, contracting with network pharmacies, controlling the cost of covered prescription drugs, or the provision of related services. ...
- https://bynum.house.gov/sites/evo-subsites/bynum.house.gov/files/evo-media-document/bynum-final-microplastics-safety-act.pdf...R. ll To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study, and submit to Congress a report, on the human health impacts of exposure to microplastics in food and water. IN THE HOUSE OF REPRESENTATIVES Ms. ...
- Miller-Meeks, Murphy, Barragan, and Kuster Introduce Bill to Expedite Substitution Process for Pharmhttps://millermeeks.house.gov/media/press-releases/miller-meeks-murphy-barragan-and-kuster-introduce-bill-expedite-substitution-0..."Our bill aims to speed up the approval process for less expensive drugs, making them available more quickly and expanding access to affordable, life-saving medications." Background: Currently, the process by which the Food and Drug Administration (FDA) approves generic drugs is different from that of biological products. ...
- Ranking Member Krishnamoorthi Demands Answers from Trump Administration on Billions in Higher Drug Chttps://krishnamoorthi.house.gov/media/press-releases/ranking-member-krishnamoorthi-demands-answers-trump-administration-billions...“President Trump’s One Big Beautiful Bill will delay or rescind CMS’s ability to negotiate the prices of costly, life-saving drugs and will actually increase the cost of prescription drugs.” Under the Inflation Reduction Act of 2022, Medicare gained the power to annually negotiate certain high-cost drugs, saving taxpayers tens of billions and reducing seniors’ out-of-pocket costs. ...
- https://crow.house.gov/sites/evo-subsites/crow.house.gov/files/evo-media-document/crowco_075_xml-wpr-jrd.pdf...The trafficking of illegal drugs does not itself constitute such an armed attack or threat of an imminent armed attack. ...
- Rep. Courtney Helps Pass Landmark Drug Pricing Bill, H.R. 3 the Lower Drug Costs Now Act | Congressmhttps://courtney.house.gov/media-center/press-releases/rep-courtney-helps-pass-landmark-drug-pricing-bill-hr-3-lower-drug...Stops drug companies ripping off Americans while charging other countries less for the same drugs , limiting the maximum price for any negotiated drug to be in line with the average price in countries like ours, where drug companies charge less for the same drugs – and admit they still make a profit. ...
- https://watsoncoleman.house.gov/newsroom/press-releases/rep-watson-coleman-votes-to-pass-the-lower-drug-costs-now-act...H.R. 3 will reduce drug costs for millions of Americans in the 12 th District and across the New Jersey: Breast Cancer : New Jersey patients could save $69,000 off the average total cost of the breast cancer medication Ibrance per year; Leukemia : New Jersey patients could save $93,000 off the average total cost of the leukemia medication Tasigna per year; Prostate Cancer : New Jersey patients could save $109,000 off the average total cost of the prostate cancer medication Zytiga per year; Arthritis : New Jersey patients could save $40,000 off their total costs on most arthritis drugs per year; Asthma : New Jersey patients could save $1,400 off their total costs on most Asthma drugs per year; HIV/AIDS : New Jersey patients could save $15,000 off their total costs on most HIV/AIDS drugs per year; Multiple Sclerosis : New Jersey patients could save $40,000 off their total costs on most MS drugs per year; Diabetes : In New Jersey, the 645,000 patients could spend 3.5 times less on insulin. ...
- https://sewell.house.gov/lowering-rx-drug-costs...In January 2025, the Biden-Harris Administration announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations. These drugs treat common conditions like type 2 diabetes, asthma, COPD, and obesity. They inlclude: In accordance with the Inflation Reduction Act, the negotiations with participating drug companies for these 15 drugs will occur in 2025 and any negotiated prices will become effective in 2027. ...
- https://courtney.house.gov/media-center/press-releases/rep-courtney-applauds-new-rx-cost-savings-seniors...In addition to these new drug price savings, the Inflation Reduction Act has lowered the cost of prescription drugs for seniors through: a $35 cap on monthly insulin copays, free shingles and other recommended vaccinations, a $2,000 out-of-pocket cap on prescription drugs beginning in 2025, and protections from drug company price hikes. ...
- Steube Pens Op-Ed in Sarasota Herald-Tribune: “Pelosi’s Drug Pricing Proposal Would put Floridians ahttps://steube.house.gov/press-releases/steube-pens-op-ed-in-sarasota-herald-tribune-pelosi-s-drug-pricing-proposal-would-put-floridians-at-risk/...And this kind of government ‘negotiation’ on drug pricing would in practice lead to American patients losing out on access to lifesaving treatments. Many of my constituents rely on prescription drugs every day to treat or manage chronic conditions. Many are living with illnesses that don’t yet have a cure. There are policies that are being discussed right now that would prevent new cures from being discovered or reduce access to existing drugs. ...